A systematic review and meta-analysis of acupoint autohemotherapy and western medicine therapy in treating chronic obstructive pulmonary disease

Complement Ther Clin Pract. 2021 May:43:101336. doi: 10.1016/j.ctcp.2021.101336. Epub 2021 Mar 11.

Abstract

Objective: To evaluate the safety and efficacy of acupoint autohemotherapy(AA).

Methods: We collected Controlled Trials that are random of AA plus medicine of the west therapy vs western medicine therapy alone in treating COPD from PubMed, the Cochrane library, EMBASE, CNKI, CBM SinoMed, China Science, and Wanfang Data from database inception to July 1, 2019. Meta-analysis was performed using the RevMan 5.3.

Results: This meta-analysis identified that the combined treatment could enhance the total effective clinical rate, the forced expiratory volume in 1 s(FEV1)and forced vital capacity(FVC),increase the 6-min walking distance,and improve the self-assessment of chronic obstructive pulmonary disease score(CAT).

Conclusion: The clinical effects of AA plus medicine of the west therapy are better than that of western medicine alone in treating COPD. However, due to the small number and poor quality of the included RCTs,this conclusion needs to be verified with larger samples and higher quality RCTs.

Keywords: AA (Acupoint autohemotherapy); COPD (Chronic obstructive pulmonary disease); Meta-analysis; RCT (Randomized controlled trial).

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Acupuncture Points*
  • China
  • Humans
  • Medicine, Chinese Traditional
  • Pulmonary Disease, Chronic Obstructive* / drug therapy
  • Respiratory Function Tests